43 related articles for article (PubMed ID: 1339150)
1. [Itraconazole action on Toxoplasma gondii].
Jamra LM; Amato Neto V; Braz LM; Camargo ME
Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(1):25-7. PubMed ID: 1339150
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasma gondii: fluconazole and itraconazole activity against toxoplasmosis in a murine model.
Martins-Duarte ES; Lemgruber L; de Souza W; Vommaro RC
Exp Parasitol; 2010 Apr; 124(4):466-9. PubMed ID: 20045696
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo.
de Oliveira TC; Silva DA; Rostkowska C; Béla SR; Ferro EA; Magalhães PM; Mineo JR
Exp Parasitol; 2009 Jul; 122(3):233-41. PubMed ID: 19389400
[TBL] [Abstract][Full Text] [Related]
4. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
Derouin F
Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
[TBL] [Abstract][Full Text] [Related]
5. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
[TBL] [Abstract][Full Text] [Related]
6. A new combined flow-cytometry-based assay reveals excellent activity against Toxoplasma gondii and low toxicity of new bisphosphonates in vitro and in vivo.
Shubar HM; Mayer JP; Hopfenmüller W; Liesenfeld O
J Antimicrob Chemother; 2008 May; 61(5):1110-9. PubMed ID: 18285314
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice].
Xiang X; Ke OY; Zhang Z
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):5-7. PubMed ID: 9868016
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
[TBL] [Abstract][Full Text] [Related]
9. Genetic resistance against acute toxoplasmosis depends on the strain of Toxoplasma gondii.
Suzuki Y; Yang Q; Remington JS
J Parasitol; 1995 Dec; 81(6):1032-4. PubMed ID: 8544050
[TBL] [Abstract][Full Text] [Related]
10. Treatment of paracoccidioidomycosis with itraconazole in a murine model.
McEwen JG; Peters GR; Blaschke TF; Brummer E; Perlman AM; Restrepo A; Stevens DA
J Trop Med Hyg; 1985 Oct; 88(5):295-9. PubMed ID: 3014164
[TBL] [Abstract][Full Text] [Related]
11. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
[TBL] [Abstract][Full Text] [Related]
12. Protection of Toxoplasma gondii-infected mice by stearylamine-bearing liposomes.
Tachibana H; Yoshihara E; Kaneda Y; Nakae T
J Parasitol; 1990 Jun; 76(3):352-5. PubMed ID: 2352064
[TBL] [Abstract][Full Text] [Related]
13. Nifurtimox plus pyrimethamine for treatment of murine toxoplasmosis.
Aguirre-Cruz L; Velasco O; Sotelo J
J Parasitol; 1998 Oct; 84(5):1032-3. PubMed ID: 9794648
[TBL] [Abstract][Full Text] [Related]
14. [Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals].
Piergili Fioretti D
Parassitologia; 2004 Jun; 46(1-2):177-81. PubMed ID: 15305712
[TBL] [Abstract][Full Text] [Related]
15. [Effects of clindamycin and josamycin in experimental Toxoplasma gondii infections].
Terragna A; Canessa A; Terragna FM; Corradino L
Minerva Med; 1984 Oct; 75(39):2305-8. PubMed ID: 6504394
[TBL] [Abstract][Full Text] [Related]
16. Itraconazole affects Toxoplasma gondii endodyogeny.
Martins-Duarte Edos S; de Souza W; Vommaro RC
FEMS Microbiol Lett; 2008 May; 282(2):290-8. PubMed ID: 18371067
[TBL] [Abstract][Full Text] [Related]
17. [Anti-Candida activity of azoles].
Van Cutsem J; Van Gerven F; Janssen PA
Ann Biol Clin (Paris); 1987; 45(6):661-8. PubMed ID: 2830810
[TBL] [Abstract][Full Text] [Related]
18. Lack of therapeutic effect of colchicine on murine toxoplasmosis.
Aguirre-Cruz L; Sotelo J
J Parasitol; 1998 Feb; 84(1):163-4. PubMed ID: 9488356
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study of the activity of the sulphamethoxypyrazine (Longum equals Kelfizina) with pyrimethamine (Daraprim) on the cysts development phase of Toxoplasma gondii in Mastomys natalensis. Further contribution to experimental chemotherapy of toxoplasmosis (author's transl)].
Werner H; Egger I
Zentralbl Bakteriol Orig A; 1974 Jun; 226(4):554-60. PubMed ID: 4152678
[No Abstract] [Full Text] [Related]
[Next] [New Search]
